Com2uS Corporation (078340) — Free Cash Flow Generation Index

Latest as of March 2026: 0.90x

Com2uS Corporation (078340) has a Free Cash Flow Generation Index of 0.90x as of March 2026. Free cash flow of ₩8.29 Billion represents 1% of operating cash flow (₩9.18 Billion). Explore reinvestment intensity of Com2uS Corporation to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.90x
Free Cash Flow / Operating CF

Free Cash Flow

₩8.29 Billion
KRW

Operating Cash Flow

₩9.18 Billion
KRW

Capital Expenditures

₩888.85 Million
KRW

Com2uS Corporation Free Cash Flow Generation Index (2011–2024)

Historical FCF Generation Index trend for Com2uS Corporation across 12 annual periods. For the full cash flow conversion analysis, see 078340 operating cash flow.

Annual Free Cash Flow Generation for Com2uS Corporation (2011–2024)

Year-by-year Free Cash Flow Generation Index for Com2uS Corporation. Check 078340 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 0.12x ₩1.79 Billion ₩15.53 Billion ₩13.74 Billion ▼ -87.3%
2021 0.91x ₩81.89 Billion ₩90.15 Billion ₩6.60 Billion ▼ -1.7%
2020 0.92x ₩94.71 Billion ₩102.54 Billion ₩2.34 Billion ▼ -10.1%
2019 1.03x ₩133.37 Billion ₩129.83 Billion ₩3.54 Billion ▲ +1.5%
2018 1.01x ₩130.17 Billion ₩128.61 Billion ₩1.56 Billion ▲ +0.4%
2017 1.01x ₩135.63 Billion ₩134.55 Billion ₩1.09 Billion ▼ -0.5%
2016 1.01x ₩158.07 Billion ₩155.99 Billion ₩2.08 Billion ▼ -1.2%
2015 1.03x ₩141.46 Billion ₩137.96 Billion ₩3.49 Billion ▲ +1.5%
2014 1.01x ₩83.92 Billion ₩83.06 Billion ₩861.14 Million ▼ -5.5%
2013 1.07x ₩11.33 Billion ₩10.60 Billion ₩729.19 Million ▼ -5.6%
2012 1.13x ₩29.61 Billion ₩26.14 Billion ₩3.47 Billion ▼ -13.7%
2011 1.31x ₩2.77 Billion ₩2.11 Billion ₩659.73 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).